| 10000 | HSAP00P0000043618 | 0.7228 | 6.574 | 2.278 | 0.03699 | 0.2102 | -4.219 | AKT3 | v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) | ENSG00000117020 | 611223 | 10000 | NM_005465 |
| 1017 | HSAP00P0000265302 | -1.668 | 8.313 | -3.318 | 0.004418 | 0.06096 | -2.226 | CDK2 | cyclin-dependent kinase 2 | ENSG00000123374 | 116953 | 1017 | NM_001798 |
| 1019 | HSAP00P0000266822 | -2.426 | 10.53 | -8.347 | 3.504e-07 | 0.0001766 | 6.915 | CDK4 | cyclin-dependent kinase 4 | ENSG00000135446 | 123829, 609048 | 1019 | NM_000075 |
| 1021 | HSAP00P0000166047 | 0.7444 | 5.664 | 1.802 | 0.09067 | 0.3344 | -5.014 | CDK6 | cyclin-dependent kinase 6 | ENSG00000105810 | 603368, 612223 | 1021 | BC027989 |
| 1027 | HSAP00P0000257729 | -2.353 | 9.168 | -4.519 | 0.000361 | 0.01247 | 0.2022 | CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | ENSG00000111276 | 600778, 610755 | 1027 | NM_004064 |
| 1030 | HSAP00P0000193540 | 0.7416 | 4.493 | 2.472 | 0.02521 | 0.1705 | -3.868 | CDKN2B | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | ENSG00000147883 | 600431 | 1030 | NM_078487 |
| 10319 | HSAP00P0000206717 | 1.21 | 6.236 | 2.94 | 0.00971 | 0.09813 | -2.976 | LAMC3 | laminin, gamma 3 | ENSG00000050555 | 604349, 614115 | 10319 | AL133595 |
| 10401 | HSAP00P0000024494 | -2.361 | 7.037 | -5.984 | 2.017e-05 | 0.002022 | 3.018 | PIAS3 | protein inhibitor of activated STAT, 3 | ENSG00000131788 | 605987 | 10401 | NM_006099 |
| 1147 | HSAP00P0000222522 | 0.5476 | 9.128 | 2.478 | 0.02493 | 0.1694 | -3.858 | CHUK | conserved helix-loop-helix ubiquitous kinase | ENSG00000213341 | 600664, 613630 | 1147 | NM_001278 |
| 1163 | HSAP00P0000028445 | -2.157 | 10.3 | -6.786 | 4.69e-06 | 0.0008256 | 4.433 | CKS1B | CDC28 protein kinase regulatory subunit 1B | ENSG00000173207 | 116900 | 1163 | AF274943 |
| 1282 | HSAP00P0000283584 | 0.849 | 3.923 | 2.922 | 0.01009 | 0.1004 | -3.012 | COL4A1 | collagen, type IV, alpha 1 | ENSG00000187498 | 120130, 175780, 607595, 611773 | 1282 | NM_001845 |
| 1284 | HSAP00P0000283618 | 1.248 | 6.827 | 2.843 | 0.01186 | 0.1106 | -3.165 | COL4A2 | collagen, type IV, alpha 2 | ENSG00000134871 | 120090 | 1284 | M24766 |
| 1286 | HSAP00P0000070443 | 1.345 | 5.134 | 2.979 | 0.008964 | 0.09363 | -2.9 | COL4A4 | collagen, type IV, alpha 4 | ENSG00000081052 | 120131, 203780 | 1286 | NM_000092 |
| 1288 | HSAP00P0000430331 | 0.9855 | 5.071 | 2.818 | 0.01249 | 0.114 | -3.213 | COL4A6 | collagen, type IV, alpha 6 | ENSG00000197565 | 303631, 308940 | 1288 | NM_033641 |
| 1869 | HSAP00P0000398637 | -2.427 | 9.004 | -5.46 | 5.488e-05 | 0.003801 | 2.042 | E2F1 | E2F transcription factor 1 | ENSG00000101412 | 189971 | 1869 | BC050369 |
| 1870 | HSAP00P0000007194 | -2.004 | 6.81 | -4.231 | 0.0006538 | 0.01819 | -0.3768 | E2F2 | E2F transcription factor 2 | ENSG00000007968 | 600426 | 1870 | NM_004091 |
| 1871 | HSAP00P0000135209 | -2.256 | 9.246 | -6.364 | 9.993e-06 | 0.001303 | 3.701 | E2F3 | E2F transcription factor 3 | ENSG00000112242 | 600427 | 1871 | D38550 |
| 207 | HSAP00P0000298189 | -1.597 | 9.721 | -6.938 | 3.59e-06 | 0.0007116 | 4.692 | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ENSG00000142208 | 114480, 114500, 164730, 167000, 176920, 181500, 604370 | 207 | NM_005163 |
| 208 | HSAP00P0000382058 | -1.688 | 10.71 | -6.842 | 4.246e-06 | 0.0007853 | 4.529 | AKT2 | v-akt murine thymoma viral oncogene homolog 2 | ENSG00000105221 | 125853, 164731 | 208 | BC063421 |
| 2272 | HSAP00P0000083731 | 1.263 | 5.847 | 3.244 | 0.005154 | 0.06707 | -2.373 | FHIT | fragile histidine triad gene | ENSG00000189283 | 601153 | 2272 | NM_002012 |
| 22798 | HSAP00P0000169998 | 1.022 | 5.505 | 2.461 | 0.02576 | 0.1724 | -3.888 | LAMB4 | laminin, beta 4 | ENSG00000091128 | NA | 22798 | AF029325 |
| 2335 | HSAP00P0000068260 | -2.507 | 6.582 | -4.552 | 0.0003373 | 0.01193 | 0.2685 | FN1 | fibronectin 1 | ENSG00000115414 | 135600, 601894 | 2335 | BC005858 |
| 23533 | HSAP00P0000337416 | 0.9619 | 7.292 | 2.967 | 0.009185 | 0.095 | -2.923 | PIK3R5 | phosphoinositide-3-kinase, regulatory subunit 5 | ENSG00000141506 | 611317 | 23533 | NM_014308 |
| 284217 | HSAP00P0000359239 | 0.9115 | 8.99 | 3.532 | 0.002818 | 0.04614 | -1.793 | LAMA1 | laminin, alpha 1 | ENSG00000101680 | 150320 | 284217 | AF351616 |
| 317 | HSAP00P0000270033 | 2.433 | 4.28 | 2.023 | 0.06031 | 0.2716 | -4.658 | APAF1 | apoptotic peptidase activating factor 1 | ENSG00000120868 | 602233 | 317 | NM_181861 |
| 329 | HSAP00P0000248283 | -0.8834 | 5.849 | -2.384 | 0.03001 | 0.1877 | -4.028 | BIRC2 | baculoviral IAP repeat containing 2 | ENSG00000110330 | 601712 | 329 | BC028578 |
| 330 | HSAP00P0000248268 | 1.018 | 6.186 | 3.533 | 0.002811 | 0.04608 | -1.791 | BIRC3 | baculoviral IAP repeat containing 3 | ENSG00000023445 | 601721 | 330 | NM_001165 |
| 331 | HSAP00P0000431694 | -1.506 | 5.704 | -3.137 | 0.006451 | 0.07685 | -2.587 | XIAP | X-linked inhibitor of apoptosis | ENSG00000101966 | 300079, 300635 | 331 | NM_001167 |
| 3551 | HSAP00P0000181780 | -0.9712 | 6.181 | -2.727 | 0.01504 | 0.1272 | -3.388 | IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | ENSG00000104365 | 603258 | 3551 | NM_001556 |
| 3655 | HSAP00P0000063679 | -0.8947 | 4.125 | -2.563 | 0.02101 | 0.1538 | -3.699 | ITGA6 | integrin, alpha 6 | ENSG00000091409 | 147556, 226730 | 3655 | X53586 |
| 3673 | HSAP00P0000117636 | 0.5649 | 3.988 | 2.123 | 0.04989 | 0.2462 | -4.489 | ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | ENSG00000164171 | 192974 | 3673 | NM_002203 |
| 3674 | HSAP00P0000347245 | 1.065 | 5.064 | 4.028 | 0.0009962 | 0.0239 | -0.7866 | ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | ENSG00000005961 | 273800, 607759 | 3674 | NM_000419 |
| 3675 | HSAP00P0000349390 | 0.8586 | 5.927 | 3.076 | 0.00733 | 0.08295 | -2.709 | ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | ENSG00000005884 | 605025 | 3675 | NM_002204 |
| 3685 | HSAP00P0000065312 | -0.8121 | 9.235 | -2.767 | 0.01388 | 0.1214 | -3.313 | ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | ENSG00000138448 | 193210 | 3685 | NM_002210 |
| 3688 | HSAP00P0000213820 | -1.873 | 9.713 | -5.612 | 4.092e-05 | 0.003157 | 2.329 | ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | ENSG00000150093 | 135630 | 3688 | NM_002211 |
| 3908 | HSAP00P0000150841 | 0.9228 | 4.877 | 2.582 | 0.02021 | 0.1505 | -3.663 | LAMA2 | laminin, alpha 2 | ENSG00000196569 | 156225, 607855 | 3908 | NM_000426 |
| 3909 | HSAP00P0000360703 | -2.681 | 7.123 | -6.84 | 4.262e-06 | 0.000786 | 4.526 | LAMA3 | laminin, alpha 3 | ENSG00000053747 | 226650, 226700, 245660, 600805 | 3909 | NM_000227 |
| 3910 | HSAP00P0000149776 | 0.5848 | 3.763 | 2.427 | 0.02757 | 0.1791 | -3.95 | LAMA4 | laminin, alpha 4 | ENSG00000112769 | 600133 | 3910 | NM_002290 |
| 3911 | HSAP00P0000403839 | -1.227 | 6.706 | -4.436 | 0.0004277 | 0.0139 | 0.03674 | LAMA5 | laminin, alpha 5 | ENSG00000130702 | 601033 | 3911 | BC003355 |
| 3912 | HSAP00P0000169965 | 0.7029 | 4.442 | 2.303 | 0.03523 | 0.205 | -4.175 | LAMB1 | laminin, beta 1 | ENSG00000091136 | 150240 | 3912 | BC026018 |
| 3913 | HSAP00P0000080494 | -1.094 | 6.806 | -3.382 | 0.003863 | 0.0562 | -2.097 | LAMB2 | laminin, beta 2 (laminin S) | ENSG00000172037 | 150325, 609049, 614199 | 3913 | NM_002292 |
| 3914 | HSAP00P0000039225 | 1.605 | 5.862 | 3.795 | 0.001622 | 0.03284 | -1.259 | LAMB3 | laminin, beta 3 | ENSG00000196878 | 150310, 226650, 226700 | 3914 | NM_000228 |
| 3915 | HSAP00P0000035359 | -2.705 | 10.48 | -7.787 | 8.573e-07 | 0.0003009 | 6.066 | LAMC1 | laminin, gamma 1 (formerly LAMB2) | ENSG00000135862 | 150290, 176780 | 3915 | NM_002293 |
| 3918 | HSAP00P0000035378 | 0.4496 | 5.605 | 1.234 | 0.2353 | 0.5295 | -5.793 | LAMC2 | laminin, gamma 2 | ENSG00000058085 | 150292, 226650, 226700 | 3918 | NM_005562 |
| 4149 | HSAP00P0000291277 | -0.9182 | 5.641 | -2.511 | 0.02333 | 0.1631 | -3.796 | MAX | MYC associated factor X | ENSG00000125952 | 154950, 171300 | 4149 | BC036092 |
| 4609 | HSAP00P0000187956 | -4.045 | 10.73 | -14.76 | 1.181e-10 | 2.478e-06 | 14.02 | MYC | v-myc myelocytomatosis viral oncogene homolog (avian) | ENSG00000136997 | 113970, 190080 | 4609 | X66258 |
| 4790 | HSAP00P0000107725 | -3.16 | 9.437 | -13.01 | 7.483e-10 | 5.588e-06 | 12.48 | NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | ENSG00000109320 | 164011 | 4790 | NM_003998 |
| 4792 | HSAP00P0000287985 | -1.472 | 9.952 | -5.949 | 2.157e-05 | 0.002111 | 2.953 | NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | ENSG00000100906 | 164008, 612132 | 4792 | BC002601 |
| 4843 | HSAP00P0000340341 | 1.029 | 5.616 | 3.294 | 0.004642 | 0.06289 | -2.273 | NOS2 | nitric oxide synthase 2, inducible | ENSG00000007171 | 145500, 163730, 248310, 611162 | 4843 | NM_000625 |
| 51588 | HSAP00P0000368050 | 0.4561 | 8.039 | 1.784 | 0.0936 | 0.3397 | -5.041 | PIAS4 | protein inhibitor of activated STAT, 4 | ENSG00000105229 | 605989 | 51588 | NM_015897 |
| 5290 | HSAP00P0000094567 | 0.6479 | 3.476 | 1.948 | 0.06943 | 0.292 | -4.782 | PIK3CA | phosphoinositide-3-kinase, catalytic, alpha polypeptide | ENSG00000121879 | 114480, 114500, 114550, 137215, 162900, 167000, 171834, 182000, 211980, 604370 | 5290 | NM_006218 |
| 5291 | HSAP00P0000091153 | -3.045 | 6.747 | -6.027 | 1.861e-05 | 0.001925 | 3.096 | PIK3CB | phosphoinositide-3-kinase, catalytic, beta polypeptide | ENSG00000051382 | 602925 | 5291 | BC003393 |
| 5293 | HSAP00P0000003287 | -2.139 | 9.05 | -5.21 | 8.965e-05 | 0.005181 | 1.563 | PIK3CD | phosphoinositide-3-kinase, catalytic, delta polypeptide | ENSG00000171608 | 602839 | 5293 | NM_005026 |
| 5294 | HSAP00P0000169745 | 0.5589 | 3.848 | 1.98 | 0.06537 | 0.2829 | -4.729 | PIK3CG | phosphoinositide-3-kinase, catalytic, gamma polypeptide | ENSG00000105851 | 601232 | 5294 | NM_002649 |
| 5295 | HSAP00P0000119062 | -2.561 | 7.635 | -5.847 | 2.614e-05 | 0.002388 | 2.765 | PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | ENSG00000145675 | 171833 | 5295 | NM_181524 |
| 5296 | HSAP00P0000375908 | -0.9965 | 7.908 | -4.125 | 0.0008143 | 0.02099 | -0.5905 | PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) | ENSG00000105647 | 603157 | 5296 | BC014170 |
| 54205 | HSAP00P0000158902 | 0.9881 | 4.51 | 2.808 | 0.01275 | 0.1155 | -3.233 | CYCS | cytochrome c, somatic | ENSG00000172115 | 123970, 612004 | 54205 | NM_018947 |
| 5728 | HSAP00P0000219804 | -0.7229 | 5.468 | -1.88 | 0.07871 | 0.3113 | -4.892 | PTEN | phosphatase and tensin homolog | ENSG00000171862 | 137800, 153480, 155600, 158350, 174900, 176807, 176920, 188470, 275355, 276950, 601728, 605309, 607174, 608089, 612242, 613028 | 5728 | NM_000314 |
| 5743 | HSAP00P0000035947 | 0.8954 | 3.995 | 2.2 | 0.04302 | 0.2281 | -4.356 | PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | ENSG00000073756 | 600262 | 5743 | NM_000963 |
| 5747 | HSAP00P0000188722 | -2.053 | 7.477 | -4.544 | 0.0003426 | 0.01205 | 0.2532 | PTK2 | PTK2 protein tyrosine kinase 2 | ENSG00000169398 | 600758 | 5747 | NM_153831 |
| 5915 | HSAP00P0000076080 | 0.8306 | 10.24 | 2.732 | 0.01491 | 0.1265 | -3.38 | RARB | retinoic acid receptor, beta | ENSG00000077092 | 180220 | 5915 | NM_000965 |
| 5925 | HSAP00P0000280585 | -1.276 | 7.01 | -3.465 | 0.003243 | 0.05045 | -1.929 | RB1 | retinoblastoma 1 | ENSG00000139687 | 109800, 180200, 182280, 259500, 614041 | 5925 | BC040540 |
| 595 | HSAP00P0000244217 | -5.498 | 10.03 | -16.28 | 2.749e-11 | 1.629e-06 | 15.18 | CCND1 | cyclin D1 | ENSG00000110092 | 114500, 151400, 168461, 193300, 254500 | 595 | NM_053056 |
| 596 | HSAP00P0000363748 | 0.8055 | 5.464 | 2.672 | 0.01686 | 0.1357 | -3.494 | BCL2 | B-cell CLL/lymphoma 2 | ENSG00000171791 | 151430 | 596 | NM_000633 |
| 5970 | HSAP00P0000242052 | 0.6637 | 9.05 | 2.44 | 0.02689 | 0.1766 | -3.927 | RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | ENSG00000173039 | 164014 | 5970 | L19067 |
| 598 | HSAP00P0000398006 | -2.708 | 7.825 | -7.673 | 1.034e-06 | 0.0003383 | 5.887 | BCL2L1 | BCL2-like 1 | ENSG00000171552 | 600039 | 598 | NM_138578 |
| 6256 | HSAP00P0000207969 | -3.653 | 7.191 | -7.984 | 6.229e-07 | 0.0002468 | 6.37 | RXRA | retinoid X receptor, alpha | ENSG00000186350 | 180245 | 6256 | U66306 |
| 6257 | HSAP00P0000140670 | -1.689 | 6.224 | -4.026 | 0.001001 | 0.024 | -0.7915 | RXRB | retinoid X receptor, beta | ENSG00000227322, ENSG00000204231, ENSG00000228333, ENSG00000206289, ENSG00000235712, ENSG00000231321 | 180246 | 6257 | NM_021976 |
| 6258 | HSAP00P0000032646 | 0.9479 | 6.379 | 3.218 | 0.005444 | 0.06932 | -2.426 | RXRG | retinoid X receptor, gamma | ENSG00000143171 | 180247 | 6258 | NM_006917 |
| 6502 | HSAP00P0000116493 | -2.087 | 6.671 | -4.222 | 0.0006652 | 0.01841 | -0.3936 | SKP2 | S-phase kinase-associated protein 2 (p45) | ENSG00000145604 | 601436 | 6502 | NM_005983 |
| 7157 | HSAP00P0000336667 | -3.681 | 7.909 | -10.61 | 1.371e-08 | 2.571e-05 | 9.918 | TP53 | tumor protein p53 | ENSG00000141510 | 114480, 114500, 114550, 151623, 161550, 191170, 202300, 259500, 260350, 260500, 607107 | 7157 | NM_000546 |
| 7185 | HSAP00P0000203169 | 0.5797 | 4.453 | 2.318 | 0.0342 | 0.2015 | -4.148 | TRAF1 | TNF receptor-associated factor 1 | ENSG00000056558 | 601711 | 7185 | NM_005658 |
| 7186 | HSAP00P0000209096 | -0.614 | 7.352 | -2.161 | 0.04638 | 0.2371 | -4.423 | TRAF2 | TNF receptor-associated factor 2 | ENSG00000127191 | 601895 | 7186 | BX538160 |
| 7187 | HSAP00P0000297488 | 0.8103 | 7.441 | 3.032 | 0.008024 | 0.08764 | -2.795 | TRAF3 | TNF receptor-associated factor 3 | ENSG00000131323 | 601896 | 7187 | NM_145725 |
| 7188 | HSAP00P0000039484 | 0.8269 | 4.339 | 2.527 | 0.0226 | 0.1601 | -3.767 | TRAF5 | TNF receptor-associated factor 5 | ENSG00000082512 | 602356 | 7188 | NM_004619 |
| 7189 | HSAP00P0000235272 | 0.9971 | 6.634 | 2.888 | 0.01081 | 0.1046 | -3.077 | TRAF6 | TNF receptor-associated factor 6 | ENSG00000175104 | 602355 | 7189 | NM_145803 |
| 842 | HSAP00P0000004673 | 0.781 | 8.572 | 2.951 | 0.009504 | 0.09691 | -2.956 | CASP9 | caspase 9, apoptosis-related cysteine peptidase | ENSG00000132906 | 602234 | 842 | NM_001229 |
| 8503 | HSAP00P0000014135 | 1.62 | 8.912 | 5.238 | 8.474e-05 | 0.005008 | 1.618 | PIK3R3 | phosphoinositide-3-kinase, regulatory subunit 3 (gamma) | ENSG00000117461 | 606076 | 8503 | NM_003629 |
| 8517 | HSAP00P0000435277 | -1.507 | 7.079 | -4.968 | 0.0001452 | 0.007012 | 1.092 | IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | ENSG00000073009 | 300248, 300291, 300301, 300584, 300636, 300640, 308300 | 8517 | AY114157 |
| 8554 | HSAP00P0000307283 | 0.5219 | 7.508 | 1.944 | 0.06987 | 0.293 | -4.788 | PIAS1 | protein inhibitor of activated STAT, 1 | ENSG00000033800 | 603566 | 8554 | NM_016166 |
| 898 | HSAP00P0000378070 | -0.6166 | 7.428 | -2.27 | 0.0376 | 0.212 | -4.234 | CCNE1 | cyclin E1 | ENSG00000105173 | 123837 | 898 | NM_001238 |
| 9063 | HSAP00P0000362328 | -1.037 | 9.064 | -3.447 | 0.003371 | 0.05168 | -1.966 | PIAS2 | protein inhibitor of activated STAT, 2 | ENSG00000078043 | 603567 | 9063 | BC015190 |
| 9134 | HSAP00P0000185442 | -0.6125 | 8.064 | -2.23 | 0.04065 | 0.2213 | -4.305 | CCNE2 | cyclin E2 | ENSG00000175305 | 603775 | 9134 | BC007015 |
| 9618 | HSAP00P0000340928 | -1.91 | 10.61 | -7.997 | 6.105e-07 | 0.0002442 | 6.389 | TRAF4 | TNF receptor-associated factor 4 | ENSG00000076604 | 602464 | 9618 | BC001769 |